Zacks Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$212K Buy
+879
New +$212K ﹤0.01% 629
2025
Q1
Sell
-632
Closed -$208K 664
2024
Q4
$208K Sell
632
-988
-61% -$324K ﹤0.01% 623
2024
Q3
$542K Buy
+1,620
New +$542K ﹤0.01% 481
2024
Q2
Sell
-887
Closed -$307K 639
2024
Q1
$307K Buy
887
+15
+2% +$5.19K ﹤0.01% 533
2023
Q4
$282K Sell
872
-26
-3% -$8.4K ﹤0.01% 538
2023
Q3
$322K Sell
898
-47
-5% -$16.8K ﹤0.01% 500
2023
Q2
$358K Sell
945
-11,019
-92% -$4.18M ﹤0.01% 502
2023
Q1
$5.73M Buy
11,964
+5,722
+92% +$2.74M 0.08% 178
2022
Q4
$2.62M Sell
6,242
-227
-4% -$95.5K 0.04% 251
2022
Q3
$2.7M Buy
6,469
+5,682
+722% +$2.37M 0.04% 230
2022
Q2
$389K Sell
787
-3,825
-83% -$1.89M 0.01% 458
2022
Q1
$2.6M Buy
4,612
+3,871
+522% +$2.18M 0.04% 253
2021
Q4
$560K Buy
741
+1
+0.1% +$756 0.01% 441
2021
Q3
$552K Sell
740
-1
-0.1% -$746 0.01% 440
2021
Q2
$477K Hold
741
0.01% 458
2021
Q1
$423K Hold
741
0.01% 430
2020
Q4
$432K Hold
741
0.01% 434
2020
Q3
$382K Hold
741
0.01% 428
2020
Q2
$335K Sell
741
-32
-4% -$14.5K 0.01% 430
2020
Q1
$271K Buy
773
+24
+3% +$8.41K 0.01% 443
2019
Q4
$277K Buy
749
+1
+0.1% +$370 0.01% 494
2019
Q3
$249K Sell
748
-3,489
-82% -$1.16M 0.01% 490
2019
Q2
$1.33M Buy
4,237
+3,493
+469% +$1.09M 0.03% 354
2019
Q1
$228K Buy
+744
New +$228K ﹤0.01% 502
2018
Q4
Sell
-744
Closed -$233K 514
2018
Q3
$233K Sell
744
-454
-38% -$142K ﹤0.01% 484
2018
Q2
$346K Buy
+1,198
New +$346K 0.01% 479
2016
Q1
Sell
-9,759
Closed -$1.35M 607
2015
Q4
$1.35M Sell
9,759
-2,492
-20% -$345K 0.04% 246
2015
Q3
$1.65M Buy
12,251
+305
+3% +$41K 0.06% 212
2015
Q2
$1.8M Buy
+11,946
New +$1.8M 0.06% 196
2014
Q4
Sell
-2,331
Closed -$264K 632
2014
Q3
$264K Sell
2,331
-373
-14% -$42.2K 0.01% 567
2014
Q2
$324K Sell
2,704
-18
-0.7% -$2.16K 0.01% 552
2014
Q1
$349K Sell
2,722
-2,311
-46% -$296K 0.01% 513
2013
Q4
$622K Buy
5,033
+1,679
+50% +$207K 0.02% 329
2013
Q3
$394K Sell
3,354
-1,329
-28% -$156K 0.02% 426
2013
Q2
$525K Buy
+4,683
New +$525K 0.02% 300